CamGene Therapeutics

📍 Cambridge, United Kingdom🗓 Founded 2024👥 9 employees💰 Last funded Aug 2025
Biotechnology Research🌐 camgenetx.com
Website LinkedIn
The WHO predicts hearing loss will impact 1 in 10 people by 2050. Medical devices are the standard of care, but they are ineffective for many people. Despite a prevalence greater than cancer or diabetes, there are currently no treatments available to treat the underlying cellular dysfunction which is the root cause of hearing loss. Lipid nanoparticle-based mRNA therapeutics were spectacularly validated as a mass market medicine through the COVID-19 pandemic. We believe the time is now to create the world’s first mass market medicine for hearing loss.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in CamGene Therapeutics?
CamGene Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did CamGene Therapeutics last raise funding?
The most recent investment in CamGene Therapeutics recorded on gritt.io was in August 2025.
When was CamGene Therapeutics founded?
CamGene Therapeutics was founded in 2024.
What industry is CamGene Therapeutics in?
CamGene Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is CamGene Therapeutics based?
CamGene Therapeutics is headquartered in Cambridge, United Kingdom.